Psilocybin and therapy for chronic cancer pain
Part of Cancer, Mental health, Pain clinical trials.
This study tests whether a drug called psilocybin, combined with psychotherapy, can help reduce chronic pain in people with cancer who are already taking opioid pain medicine. If you qualify, you'll receive the study treatment and be closely monitored to see if your pain and quality of life improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a diagnosis of active cancer (any stage).
- You must have had moderate to severe chronic pain (score of 4 or higher on a 0-10 scale) for at least 3 months, caused by your cancer or its treatment.
- You must be on a stable dose of opioid pain medication for at least one month before starting.
- You must not have used illegal drugs (other than cannabis) in the past year.
- You must be able to speak, read, and write in English, and be able to swallow pills.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.
This trial tests whether psilocybin (a psychedelic medication) can help people who have both chronic nerve pain and depression that hasn't responded to standard treatments. The goal is to see if it can reduce pain and improve mood.
This study tests whether a therapy combining psilocybin (a psychedelic substance) with counseling can help improve emotional well-being in people with advanced cancer who have symptoms of depression. It aims to see if this approach can ease suffering and improve quality of life.
This trial tests whether psilocybin (a psychedelic drug) can help with severe cancer pain. You may qualify if your pain is high despite strong medications and you are willing to be monitored closely.
This trial studies whether psilocybin (with support and therapy) can reduce anxiety in people with advanced cancer. It may help with distress and quality of life, while the study team monitors safety closely.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
Hear when a new Hematopoietic and Lymphatic System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.